Impact of the Protocol on the provision of medicines to Northern Ireland

Wednesday 6 October 2021 -

Publication types - Scrutiny evidence

RSS

• Teva UK Limited - written evidence, dated 18 January 2022

  Thursday 27 January 2022 @ 12:15

• PAGB, the consumer healthcare association – written evidence, dated 17 January 2022

  Thursday 27 January 2022 @ 12:10

• Healthcare Distribution Association (HDA UK) – written evidence, dated 17 January 2022

  Thursday 27 January 2022 @ 12:10

• Norgine Pharmaceuticals – Supplementary written evidence, 8 November 2021

  Wednesday 17 November 2021 @ 17:50

• PAGB – Further supplementary written evidence, 4 November 2021

  Wednesday 17 November 2021 @ 17:45

• Teva UK – Further supplementary written evidence, 1 November 2021

  Wednesday 17 November 2021 @ 17:40

• PAGB - Supplementary written evidence on the provision of medicines to Northern Ireland, 18 October 2021

  Wednesday 10 November 2021 @ 14:40

• Teva UK Limited – Supplementary written evidence on the provision of medicines to Northern Ireland, 14 October 2021

  Tuesday 26 October 2021 @ 13:05

• Ethical Medicines Industry Group – Written evidence on the provision of medicines to Northern Ireland, 11 October 2021

  Tuesday 26 October 2021 @ 13:00